Skip to content

Interest of the Tool: Evaluation of Specific Care in an Ecological Environment for Patients Suffering From Schizophrenia-like Disorders

Interest of the Tool: Evaluation of Specific Care in an Ecological Environment for Patients Suffering From Schizophrenia-like Disorders

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05349513
Acronym
IEvaEcoSchi
Enrollment
56
Registered
2022-04-27
Start date
2022-02-23
Completion date
2026-02-28
Last updated
2026-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients With Schizophrenia-like Disorders

Brief summary

The study use a new ecological questionnaire called ESSME developed by a care team in order to evaluate ecological environment of patients with schizophrenia-like disorders. Indeed, evaluation in an ecological environment would make it possible to be as close as possible to the concerns of theses patients, which could improve the care of this population, by making it possible to set with the patient objectives anchored in their daily life.

Detailed description

The duration of patient's participation to the study is 6 months plus 7 to 14 days. The study includes the following visits : * V0: Inclusion visit (Day 0) with the administration of standard of care questionnaires; * V1: visit at patient's home (Day 0 +7 to 14 days) with the administration of the experimental ESSME questionnaire; * V2: follow-up visit at 6 months (M6) with the administration of the same standard of care questionnaires than at the inclusion visit; * V3: visit at patient's home (M6 + 7 to 14 days) with the administration of the experimental ESSME questionnaire.

Interventions

OTHERESSME questionnaire

The experimental ecological questionnaire ESSME is administered 7 to 14 days after the inclusion visit and 7 to 14 days after the 6 months follow-up visit to the patient at their home.

Sponsors

Centre Hospitalier Henri Laborit
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* man or woman aged 18 to 65 inclusive; * diagnosis of schizophrenia or schizoaffective disorder according to the Diagnostic and Statistical Manual of Mental Disorders version number 5 (DSM-V) criteria; * patient receiving care in a Center for Rehabilitation and Intersectoral Therapeutic Activities (CREATIV); * person who consented to the study; * affiliate or beneficiary of a social security scheme.

Exclusion criteria

* patient aged under 18 or over 65; * pregnant or breastfeeding women; * person unable or unwilling to receive a home visit; * person not consenting to the study; * presence of a diagnosis of an associated neurodevelopmental disorder; * presence of a diagnosis of dementia or associated neurodegenerative process; * person with a level of French language insufficient to understand the items.

Design outcomes

Primary

MeasureTime frameDescription
Correlation coefficient between the total ecological questionnaire (ESSME) score and the total score of the social autonomy scale.6 monthsThe main judgment criterion is the correlation coefficient between the change in the total ESSME score and the change in the total score of the selected autonomy scale, the EAS over a period of 6 months. The judgment criterion will be obtained by calculating a percentage variation between the initial total score and that obtained at 6 months for each of the scales: EAS and for the ESSME tool.

Countries

France

Contacts

Primary ContactCarole WANGERMEZ
carole.wangermez@ch-poitiers.fr+33 5 49 38 00 19

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026